SG10201704135QA - Method For Eliciting An Immune Response To An Immunogen - Google Patents
Method For Eliciting An Immune Response To An ImmunogenInfo
- Publication number
- SG10201704135QA SG10201704135QA SG10201704135QA SG10201704135QA SG10201704135QA SG 10201704135Q A SG10201704135Q A SG 10201704135QA SG 10201704135Q A SG10201704135Q A SG 10201704135QA SG 10201704135Q A SG10201704135Q A SG 10201704135QA SG 10201704135Q A SG10201704135Q A SG 10201704135QA
- Authority
- SG
- Singapore
- Prior art keywords
- eliciting
- immunogen
- immune response
- immune
- response
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG2012084836 | 2012-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201704135QA true SG10201704135QA (en) | 2017-06-29 |
Family
ID=54321064
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201503876YA SG11201503876YA (en) | 2012-11-19 | 2013-11-11 | Method for eliciting an immune response to an immunogen |
SG10201704135QA SG10201704135QA (en) | 2012-11-19 | 2013-11-11 | Method For Eliciting An Immune Response To An Immunogen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201503876YA SG11201503876YA (en) | 2012-11-19 | 2013-11-11 | Method for eliciting an immune response to an immunogen |
Country Status (8)
Country | Link |
---|---|
US (3) | US9962438B2 (en) |
EP (1) | EP2919758B1 (en) |
JP (3) | JP6453757B2 (en) |
CN (2) | CN104936579B (en) |
MY (1) | MY175416A (en) |
PH (1) | PH12015501101A1 (en) |
SG (2) | SG11201503876YA (en) |
WO (1) | WO2014077781A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201503876YA (en) * | 2012-11-19 | 2015-06-29 | Agency Science Tech & Res | Method for eliciting an immune response to an immunogen |
US10821078B2 (en) * | 2016-06-30 | 2020-11-03 | Northwestern University | Nanostructure enhanced targeting (NSET) of inflammatory cells |
CN110945076B (en) * | 2017-09-12 | 2023-10-17 | 苏黎士联邦理工大学 | Transmembrane pH-gradient polymer vesicles for quantification of ammonia in body fluids |
EP3743101A2 (en) * | 2018-01-25 | 2020-12-02 | ACM Biolabs Pte Ltd | Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof |
US20220105176A1 (en) | 2018-09-12 | 2022-04-07 | Acm Biolabs Pte Ltd | Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof |
CN110327298A (en) * | 2019-07-30 | 2019-10-15 | 天津大学 | The preparation method of long-circulating target genophore based on PCL-PEG polymer vesicle |
CN114502191A (en) * | 2019-08-01 | 2022-05-13 | Acm生物实验室私人有限公司 | Method of eliciting an immune response by administering a population of polymersomes with associated antigens and a population of polymersomes with associated adjuvants and composition comprising both populations of polymersomes |
EP4138899A2 (en) | 2020-04-24 | 2023-03-01 | ACM Biolabs Pte Ltd | Vaccine against human-pathogenic coronaviruses |
CA3193643A1 (en) | 2020-12-11 | 2022-06-16 | Madhavan Nallani | Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant |
AU2022216818A1 (en) | 2021-02-02 | 2023-07-27 | Acm Biolabs Pte Ltd | Sole use of polymersome associated adjuvant for stimulating an immune response |
WO2022218957A1 (en) | 2021-04-12 | 2022-10-20 | Acm Biolabs Pte Ltd | Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof |
WO2023161378A1 (en) | 2022-02-23 | 2023-08-31 | Acm Biolabs Pte Ltd | Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6835394B1 (en) * | 1999-12-14 | 2004-12-28 | The Trustees Of The University Of Pennsylvania | Polymersomes and related encapsulating membranes |
US7682603B2 (en) | 2003-07-25 | 2010-03-23 | The Trustees Of The University Of Pennsylvania | Polymersomes incorporating highly emissive probes |
US8821859B2 (en) * | 2004-05-19 | 2014-09-02 | Agency For Science, Technology And Research | Methods and articles for the delivery of therapeutic agents |
US20080312581A1 (en) * | 2007-06-06 | 2008-12-18 | Biovaluation & Analysis, Inc. | Peptosomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
EP2180881A2 (en) | 2007-07-20 | 2010-05-05 | Basf Se | Vesicles comprising a transmembrane transport trigger system |
WO2009076174A1 (en) * | 2007-12-05 | 2009-06-18 | The Board Of Trustees Of The University Of Illinois | Highly permeable polymer membranes |
SG175741A1 (en) * | 2009-04-20 | 2011-12-29 | Agency Science Tech & Res | Vesicular system and uses thereof |
US8470891B2 (en) * | 2009-12-23 | 2013-06-25 | International Business Machines Corporation | Biodegradable block polymers for drug delivery, and methods related thereto |
WO2011109512A1 (en) | 2010-03-02 | 2011-09-09 | Vindico Nanobio Technology, Inc. | Compositions and methods for treating or preventing immuno-inflammatory disease |
GB201008364D0 (en) * | 2010-05-20 | 2010-07-07 | Geneve De | Composition and method |
WO2012018306A1 (en) | 2010-08-05 | 2012-02-09 | Agency For Science, Technology And Research | A multicompartmentalized vesicular structure and a method for forming the same |
GB201111216D0 (en) * | 2011-07-01 | 2011-08-17 | Reckitt & Colman Overseas | Composition and method |
SG11201503876YA (en) * | 2012-11-19 | 2015-06-29 | Agency Science Tech & Res | Method for eliciting an immune response to an immunogen |
WO2016055611A1 (en) * | 2014-10-09 | 2016-04-14 | Universität Basel | Self-assembled nanostructures and methods of use thereof |
EP3743101A2 (en) * | 2018-01-25 | 2020-12-02 | ACM Biolabs Pte Ltd | Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof |
-
2013
- 2013-11-11 SG SG11201503876YA patent/SG11201503876YA/en unknown
- 2013-11-11 CN CN201380070982.5A patent/CN104936579B/en active Active
- 2013-11-11 EP EP13855088.4A patent/EP2919758B1/en active Active
- 2013-11-11 WO PCT/SG2013/000478 patent/WO2014077781A1/en active Application Filing
- 2013-11-11 CN CN202010019429.0A patent/CN111450060A/en active Pending
- 2013-11-11 JP JP2015543011A patent/JP6453757B2/en active Active
- 2013-11-11 SG SG10201704135QA patent/SG10201704135QA/en unknown
- 2013-11-11 US US14/646,008 patent/US9962438B2/en active Active
- 2013-11-11 MY MYPI2015701618A patent/MY175416A/en unknown
-
2015
- 2015-05-18 PH PH12015501101A patent/PH12015501101A1/en unknown
-
2018
- 2018-03-28 US US15/939,232 patent/US11241494B2/en active Active
- 2018-09-28 JP JP2018183858A patent/JP6777705B2/en active Active
-
2020
- 2020-07-29 JP JP2020127822A patent/JP2020183438A/en active Pending
-
2022
- 2022-01-14 US US17/576,800 patent/US20220133883A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
PH12015501101B1 (en) | 2015-07-27 |
CN104936579B (en) | 2020-02-07 |
US11241494B2 (en) | 2022-02-08 |
US20220133883A1 (en) | 2022-05-05 |
US20180214540A1 (en) | 2018-08-02 |
EP2919758B1 (en) | 2020-09-30 |
CN111450060A (en) | 2020-07-28 |
EP2919758A4 (en) | 2016-08-17 |
EP2919758A1 (en) | 2015-09-23 |
CN104936579A (en) | 2015-09-23 |
WO2014077781A1 (en) | 2014-05-22 |
JP6777705B2 (en) | 2020-10-28 |
JP6453757B2 (en) | 2019-01-16 |
SG11201503876YA (en) | 2015-06-29 |
US9962438B2 (en) | 2018-05-08 |
JP2019011358A (en) | 2019-01-24 |
US20150297711A1 (en) | 2015-10-22 |
PH12015501101A1 (en) | 2015-07-27 |
JP2016500071A (en) | 2016-01-07 |
JP2020183438A (en) | 2020-11-12 |
MY175416A (en) | 2020-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201704135QA (en) | Method For Eliciting An Immune Response To An Immunogen | |
ZA201501833B (en) | Method for obtaining 1-kestone | |
GB2501785B (en) | Synchronisation method | |
HK1214640A1 (en) | Method for connecting parts relative to one another | |
ZA201409539B (en) | Method for obtaining higher alcohols | |
HUE050677T2 (en) | Structure and method for strain-relieved tsv | |
SG11201501044RA (en) | Extraction method | |
EP2884522A4 (en) | Semiconductor device producing method | |
HK1204275A1 (en) | Method for the preparation of dendritic cell vaccines | |
EP2937328A4 (en) | Alcohol production method | |
GB201220940D0 (en) | Method P | |
GB201222693D0 (en) | Novel method | |
EP2837619A4 (en) | Method for producing beta -alkoxypropionamide | |
SI2872536T1 (en) | Method for extracting biomass | |
SG11201408326TA (en) | Preparation method for perfluoro-2-methyl-3-pentanone and intermediate | |
PL2809816T3 (en) | Expression method | |
HK1217414A1 (en) | Method for manufacturing tea extract | |
EP2869330A4 (en) | Method for producing semiconductor device | |
HK1206731A1 (en) | Method for preparing substituted triazolopyridines | |
EP2824130A4 (en) | Method for producing polydialkylsilane | |
EP2880048A4 (en) | Method | |
EP2762448A4 (en) | Method for preparing silicon oxide | |
SI2844076T1 (en) | Method for obtaining plant proteins | |
EP2907817A4 (en) | Method for preparing cu-btc and nano-cu-btc | |
ZA201504517B (en) | Method for preparing methyl acetate |